S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

NGM NGM Biopharmaceuticals Inc

1.54

0.00 (0.00%)

Jan 08 2025 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

NGM Biopharmaceuticals (NASDAQ:NGM)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more NGM Biopharmaceuticals Charts.

NGM Biopharmaceuticals (NASDAQ:NGM)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more NGM Biopharmaceuticals Charts.

NGM Biopharmaceuticals Inc News

NGM Bio Announces Closing of Tender Offer
Friday 5 April 2024 (9 months ago) • GlobeNewswire Inc.

NGM Bio to Present Two Posters Highlighting Clinical Data from the Ongoing Phase 1/2 Clinical Trial of NGM707, a Dual ILT2/ILT4 Antagonist Antibody Product Candidate, at AACR 2024 Annual Meeting
Tuesday 19 March 2024 (10 months ago) • GlobeNewswire Inc.

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Monday 11 March 2024 (10 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 11 March 2024 (10 months ago) • Edgar (US Regulatory)

NGM Bio Provides Recent Business Highlights and Reports Fourth Quarter and Full Year 2023 Financial Results
Monday 11 March 2024 (10 months ago) • GlobeNewswire Inc.

Form SC 13E3 - Going private transaction by certain issuers
Friday 8 March 2024 (10 months ago) • Edgar (US Regulatory)

Form SC 14D9 - Solicitation, recommendation statements
Friday 8 March 2024 (10 months ago) • Edgar (US Regulatory)

Form SC14D9C - Written communication relating to third party tender offer
Monday 26 February 2024 (10 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 26 February 2024 (10 months ago) • Edgar (US Regulatory)

NGM Bio Has Entered into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group, LP
Monday 26 February 2024 (10 months ago) • GlobeNewswire Inc.

NGM Bio to Participate in the Cowen 44th Annual Health Care Conference
Tuesday 20 February 2024 (11 months ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (11 months ago) • Edgar (US Regulatory)

More NGM Biopharmaceuticals Inc News Articles

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions